Saneto RP. Mitochondrial diseases: expanding the diagnosis in the era of genetic testing. J Transl Genet Genom. 2020;4:384–428.

PubMed  PubMed Central  Google Scholar 

Emmanuele V, Ganesh J, Vladutiu G, Haas R, Kerr D, Saneto RP, et al. Time to harmonize mitochondrial syndrome nomenclature and classification: a consensus from the North American Mitochondrial Disease Consortium, (NAMDC). Mol Genet and Metab. 2022;136:125–31.

Article  CAS  Google Scholar 

Russell OM, Gorman GS, Lightolers RN, Turnbull DM. Mitochondrial diseases: hope for the future. Cell. 2020;181:168–88.

Article  CAS  PubMed  Google Scholar 

Karaa A, Klopstock T. Clinical trials in mitochondrial diseases. Handb Clin Neurol. 2023;194:229–50.

Article  PubMed  Google Scholar 

DiVito D, Wellik A, Burfield J, Peterson, J, Flickinger J, Tindall A, et al. Clinical nutrition in mitochondrial disease correlates to improved muscle fatigue, strength, and quality of life. Neurotherapeutics. 2023 (this issue).

Liesa M, Shirihai OS. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013;2(17):491–506.

Article  Google Scholar 

Sturm G, Karan KR, Monzel AS, Santhanam B, Taivassalo T, Bris C, et al. OxPhos defects cause hypermetabolism and reduce lifespan in cells and in patients with mitochondrial diseases. Commun Biol. 2023;6:22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kyriazis ID, Vassi E, Alvanou M, Angelakis C, Skaperda Z, Tekos F, et al. The impact of diet upon mitochondrial physiology (Review). Int J Mol Med. 2022;50:135.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karaa A, Kriger J, Grier J, Holbert A, Thompson JL, Parikh S, et al. Mitochondrial disease patients’ perception of dietary supplements’ use. Mol Genet Metab. 2016;119:100–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zolkipli-Cunningham Z, Xiaxo R, Stoddan A, McCormick EM, Holberts A, Burrill N, et al. Mitochondrial disease patient motivations and barriers to participate in clinical trials. PLoS ONE. 2018;13:e0197513.

Article  PubMed  PubMed Central  Google Scholar 

Madsen KL, Buch AE, Cohen BH, Falk MJ, Goldsberry A, Goldstein A, et al. Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy: MOTOR trial. Neurology. 2020;18(94):e687–98.

Article  Google Scholar 

Karaa A, Haas R, Goldstein A, Vockley J, Cohen BH. A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy. J Cachexia Sarcopenia Muscle. 2020;11(4):909–18.

Article  PubMed  PubMed Central  Google Scholar 

Karaa A, Haas R, Goldstein A, Vockley J, Weaver WD, Cohen BH. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy. Neurology. 2018;90:e1212–21. Erratum in: Neurology. 2018;90:669. Erratum in: Neurology. 2018 Nov 20; 91:986.

Article  CAS  PubMed  PubMed Central  Google Scholar